-
U.S. court ruling against DNA patent means money saved for Canadian healthcare
A U.S. Supreme Court ruling that says you can’t “own” DNA is a reason to celebrate for both our patients and innovative researchers. America’s highest court has ruled unanimously that “products of nature” cannot be patented. The ruling overturned a lower federal court decision to allow Myriad Genetics’ patent of two human genes—BRCA1 and BRCA2. This is going to have a positive effect on both cancer testing costs and genetic testing more generally.